-
Membranoproliferative glonerulonephritis (MPGN) is a relatively-rare, immune-mediated kidney
disease. All current therapies are inadequate and MPGN frequently leads to kidney failure.
This study is a 10 patient trial of the monoclonal antibody rituximab for adult patients
with MPGN. Study patients will receive 2 doses of rituximab intravenously on days 1 and 15
and will ...
Location: Mayo Clinic
Status: Active, not recruiting
» Read more
-
Investigation of the causes of genetic defects relating to hereditary urologic malignancies
will be undertaken. These rare disorders result from inherited or newly arising mutations
in genes involved in the development and function of different organ systems. As specific
disease syndromes are recognized and the responsible genes identified, mutations in
individual fami...
Location: National Cancer Institute (NCI)
Status: Completed
» Read more
-
Apparent mineralocorticoid excess (AME) is a rare inherited disease that can cause severe
high blood pressure and low blood potassium in children and adults. It is caused by abnormal
hormone metabolism and can be fatal. This study will focus on the genetic basis, natural
history, disease progression, and survival of people with AME.
Location: Mount Sinai School of Medicine
Status: Recruiting
» Read more
-
This study will examine and test patients with neonatal onset multi-system inflammatory
disease (NOMID) to learn more about the cause and course of the disease. It will study the
disease signs and symptoms and the possible role of a gene called CIAS1, and it will develop
a database to gather information on patients with NOMID in the United States and around the
world. ...
Location: National Institutes of Health Clinical Center, ...
Status: Recruiting
» Read more
-
The purpose of this study is to investigate the safety and efficacy of isavuconazole in the
treatment of invasive fungal infections that are caused by aspergillus and rare fungi.
Status: Active, not recruiting
» Read more
-
Idiopathic retroperitoneal fibrosis (IRF) is a rare disease characterised by the presence of
a retroperitoneal periaortic fibro-inflammatory tissue which may entrap the ureters and
cause renal failure. The treatment of IRF is not well established. Corticosteroids are
frequently used, but the anti-estrogen agent tamoxifen has also been reported to be
effective in a number...
Location: Department of Clinical Medicine Nephrology and ...
Status: Active, not recruiting
» Read more
-
Pulmonary lymphoangioleiomyomatosis (LAM) is a rare destructive lung disease typically
affecting women of childbearing age. Currently, there is no effective therapy for the
disease and the prognosis is poor.
In order to better study this disease, the National Heart, Lung, and Blood Institute (NHLBI)
has developed a registry to keep an official record of patients diagno...
Location: National Heart, Lung and Blood Institute (NHLBI)
Status: Completed
» Read more
-
The annual number of cases of clinical malaria worldwide is estimated to be 300-500 million
leading to 1.5 million deaths. Delayed care and frequent drug resistance of Plasmodium
falciparum (Pf), the most frequent form of malaria, is responsible for these deaths. Each
year, 5000-8000 travellers return to France with malaria, 4/5 from Africa and with Pf.
Clinical featur...
Location: Hopital BICHAT CLAUDE BERNARD
Status: Recruiting
» Read more
-
Gastroentero-pancreatic neuroendocrine tumours (GEP-NETs) are regarded as a fairly rare
disease. They are derived from the neuroendocrine system of the gastrointestinal tract and
the pancreas and share common clinical features. So far, there is still uncertainty about
the cell biology and mechanistic regulation of these tumours. Therefore targeted treatment
is limited an...
Location: Div. of Endocrinology, Diabetes and Clinical Nu...
Status: Recruiting
» Read more
-
The purpose of this natural history study is to understand more about the progression of
infantile Krabbe disease, a very rare genetic disease. There is very little published
longitudinal data with only anecdotal cases. This natural history study will be important in
understanding the effect of future therapies that are presently in the preclinical phase.
Location: University of North Carolina at Chapel Hill
Status: Recruiting
» Read more